Sponsor Dossier
Accord Healthcare
Sponsor Dossier for Accord Healthcare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACCOZOLE
- Brand: ACICLOVIR
- Brand: ANASTROZOLE
- Brand: Anidulafungin
- Brand: APO-Tadalafil
- Brand: ARIPADOL
- Brand: ARIPIPRAZOLE
- Brand: ARX-GLIMEPIRIDE
- Device (sponsor): Subcutaneous/intramuscular injection set, medicated
About
Accord Healthcare is an Australian Private Company with ABN 49110502513, registered in Victoria. The entity status is Active.
Portfolio
Accord Healthcare has 138 brands on the ARTG, of which 66 are indexable. The portfolio includes 59 brands with Product Information on file, 6 brands with at least one PBS-listed item, 5 brands with PBAC outcomes on record, and 7 brands with AusPARs on record.
Therapeutic focus —
Oncology: 41 brands — Neurology: 30 brands — Endocrinology: 20 brands — Cardiology: 13 brands — Urology: 8 brands — Pain & Anaesthesia: 5 brands — Immunology: 5 brands — Infectious Disease: 4 brands — Respiratory: 4 brands — Dermatology: 3 brands — Gastroenterology: 3 brands — Other: 2 brands
PBS footprint
Six brands in the Accord Healthcare portfolio have at least one PBS-listed item, with the latest PBS schedule date touched on 2026-05-01.
Regulatory activity
The latest PBAC outcome for Accord Healthcare was issued on 2025-12-01, with 5 brands holding PBAC outcomes on record. The latest AusPAR was issued on 2026-03-26, with 7 brands holding AusPARs on record.